Tobira Therapeutics, a clinical-stage biopharmaceutical company advancing cenicriviroc in liver disease and HIV, announced today that Laurent Fischer, MD, Tobira's Chairman of the Board, has been appointed Chief Executive Officer.
http://ift.tt/1iABMVT
http://ift.tt/1iABMVT
No comments:
Post a Comment